CD79A and Raynaud disease: ESR (p=0.058), gammaglobulin (p>0.05), Schirmer-I tests (p>0.05), SL/SM salivary (p>0.05), flow measurements (p>0.05), BUT or rose bengal staining (NS, data not shown). Post-treatment LFS (p=0.101) and IgA% (p=0.621). Raynaud syndrome (NS).